{"id":3012,"date":"2025-11-12T10:09:08","date_gmt":"2025-11-12T10:09:08","guid":{"rendered":"http:\/\/64.91.227.149\/~theclassactionne\/?p=311"},"modified":"2025-11-30T23:44:56","modified_gmt":"2025-11-30T23:44:56","slug":"xarelto-rivaroxaban","status":"publish","type":"post","link":"https:\/\/usclassactions.com\/?p=3012","title":{"rendered":"Xarelto (rivaroxaban)"},"content":{"rendered":"<p>Xarelto is a prescription pain medication first approved by the\u00a0FDA in July of 2011. The drug is co-marketed by\u00a0Bayer and Johnson &amp; Johnson. The medication is prescribed for three primary purposes: reducing the risk of strokes and blood clots after a diagnosis of atrial fibrillation; reducing the risk of blood clot and stroke when patients undergo knee replacement or hip replacement procedures; and\u00a0treatment of pulmonary embolisms or deep vein thrombosis.<\/p>\n<p>Individuals taking Xarelto have suffered various bleeding events leading to death.\u00a0Lawyers are pursuing cases where Xarelto users have suffered injuries such as pulmonary embolism, deep vein thrombosis, gastrointestinal hemorrhage and hemorrhage and death.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xarelto is a prescription medicine with three primary uses: to reduce the risk of blood clots and stroke in patients with atrial fibrillation; to treat deep vein thrombosis and pulmonary embolism; and to reduce the risk of blood clots in patients undergoing knee or hip replacement surgery . <\/p>\n","protected":false},"author":1,"featured_media":2513,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[16],"tags":[],"class_list":["post-3012","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-drugs-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/posts\/3012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/usclassactions.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3012"}],"version-history":[{"count":1,"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/posts\/3012\/revisions"}],"predecessor-version":[{"id":3626,"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/posts\/3012\/revisions\/3626"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/usclassactions.com\/index.php?rest_route=\/wp\/v2\/media\/2513"}],"wp:attachment":[{"href":"https:\/\/usclassactions.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usclassactions.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usclassactions.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}